HCAL
WST icon

HURRICANE CAPITAL ADVISORS LLC’s West Pharmaceutical WST Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
+520
New +$159K 0.05% 373
2024
Q3 		– Sell
-100
Closed -$32.9K – 659
2024
Q2 		$32.9K Sell
100
-575
-85% -$203K 0.01% 422
2024
Q1 		$267K Buy
675
+16
+2% +$5.92K 0.07% 181
2023
Q4 		$232K Buy
+659
New +$233K 0.09% 142

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's WST Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in West Pharmaceutical (WST) in Q2 2026: 520 shares worth $187K. The stake represents 0.05% of the portfolio and ranks #373 among its holdings. This is a return to the name: HURRICANE CAPITAL ADVISORS LLC previously reported a position in WST as recently as Q2 2024.

HURRICANE CAPITAL ADVISORS LLC first reported a position in WST in Q4 2023 and has held it in 4 quarters since. The position peaked at $267K in Q1 2024. 839 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 520 shares of West Pharmaceutical worth $187K as of Q2 2026.
  • West Pharmaceutical was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
  • West Pharmaceutical made up 0.05% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #373 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in West Pharmaceutical in Q4 2023 and has held it in 4 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's West Pharmaceutical position peaked at $267K in Q1 2024.
  • 839 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.